L
Long Beach Clinical Trials Services, Inc | Long Beach, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Atogepant
Maridebart Cafraglutide
Tolperisone
PF-06882961
PF-06651600
PF-06700841
Erenumab
Permethrin
Centanafadine
VX-548
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 18 total trials
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Locations recently updated
The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with o...
Enrolling
Overweight
Obesity
Drug: Maridebart cafraglutide
Drug: Placebo
Trial sponsors
N
A
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems